Миелосупресия Лечението с Tasigna се свързва с (National Cancer Institute Common Toxicity Criteria степен 3- 4) тромбоцитопения, неутропения и анемия.
Myelosuppressio A Tasigna- kezelés (National Cancer Institute Common Toxicity Criteria 3- 4. fokú) thrombocytopenia, neutropenia és anaemia kialakulásával jár.